212 related articles for article (PubMed ID: 29472293)
21. Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW7.
Boretto M; Geurts MH; Gandhi S; Ma Z; Staliarova N; Celotti M; Lim S; He GW; Millen R; Driehuis E; Begthel H; Smabers L; Roodhart J; van Es J; Wu W; Clevers H
Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2309902121. PubMed ID: 38483988
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor.
Tripathi V; Kaur E; Kharat SS; Hussain M; Damodaran AP; Kulshrestha S; Sengupta S
J Biol Chem; 2019 Sep; 294(36):13224-13232. PubMed ID: 31346036
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase-3-mediated phosphorylation of serine 73 targets sterol response element binding protein-1c (SREBP-1c) for proteasomal degradation.
Dong Q; Giorgianni F; Beranova-Giorgianni S; Deng X; O'Meally RN; Bridges D; Park EA; Cole RN; Elam MB; Raghow R
Biosci Rep; 2015 Nov; 36(1):e00284. PubMed ID: 26589965
[TBL] [Abstract][Full Text] [Related]
24. GSK3β-SCFFBXW7α mediated phosphorylation and ubiquitination of IRF1 are required for its transcription-dependent turnover.
Garvin AJ; Khalaf AHA; Rettino A; Xicluna J; Butler L; Morris JR; Heery DM; Clarke NM
Nucleic Acids Res; 2019 May; 47(9):4476-4494. PubMed ID: 30854564
[TBL] [Abstract][Full Text] [Related]
25. FBXW7: a critical tumor suppressor of human cancers.
Yeh CH; Bellon M; Nicot C
Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
[TBL] [Abstract][Full Text] [Related]
26. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
[TBL] [Abstract][Full Text] [Related]
27. mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.
Koo J; Yue P; Deng X; Khuri FR; Sun SY
Mol Cell Biol; 2015 Jul; 35(13):2344-55. PubMed ID: 25918246
[TBL] [Abstract][Full Text] [Related]
28. FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2.
Jiménez-Izquierdo R; Morrugares R; Suanes-Cobos L; Correa-Sáez A; Garrido-Rodríguez M; Cerero-Tejero L; Khan OM; de la Luna S; Sancho R; Calzado MA
Cell Death Dis; 2023 Mar; 14(3):202. PubMed ID: 36934104
[TBL] [Abstract][Full Text] [Related]
29. MALAT1 recruited the E3 ubiquitin ligase FBXW7 to induce CRY2 ubiquitin-mediated degradation and participated in trophoblast migration and invasion.
Wu L; Liu Q; Fan C; Yi X; Cheng B
J Cell Physiol; 2021 Mar; 236(3):2169-2177. PubMed ID: 32776544
[TBL] [Abstract][Full Text] [Related]
30. Homo-trimerization is essential for the transcription factor function of Myrf for oligodendrocyte differentiation.
Kim D; Choi JO; Fan C; Shearer RS; Sharif M; Busch P; Park Y
Nucleic Acids Res; 2017 May; 45(9):5112-5125. PubMed ID: 28160598
[TBL] [Abstract][Full Text] [Related]
31. Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
Kearns CA; Ravanelli AM; Cooper K; Appel B
J Neurosci; 2015 Nov; 35(44):14861-71. PubMed ID: 26538655
[TBL] [Abstract][Full Text] [Related]
32. Lysine-52 stabilizes the MYC oncoprotein through an SCF
De Melo J; Kim SS; Lourenco C; Penn LZ
Oncogene; 2017 Dec; 36(49):6815-6822. PubMed ID: 28806398
[TBL] [Abstract][Full Text] [Related]
33. The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development.
de la Cova CC
Cells; 2023 Aug; 12(17):. PubMed ID: 37681873
[TBL] [Abstract][Full Text] [Related]
34. FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.
Cui D; Xiong X; Shu J; Dai X; Sun Y; Zhao Y
Cell Rep; 2020 Jan; 30(2):497-509.e4. PubMed ID: 31940492
[TBL] [Abstract][Full Text] [Related]
35. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
36. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells.
An HJ; Lee CJ; Lee GE; Choi Y; Jeung D; Chen W; Lee HS; Kang HC; Lee JY; Kim DJ; Choi JS; Cho ES; Choi JS; Cho YY
Exp Mol Med; 2022 Jan; 54(1):35-46. PubMed ID: 35022544
[TBL] [Abstract][Full Text] [Related]
37. E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation.
Kumar Y; Kapoor I; Khan K; Thacker G; Khan MP; Shukla N; Kanaujiya JK; Sanyal S; Chattopadhyay N; Trivedi AK
J Biol Chem; 2015 Dec; 290(52):30975-87. PubMed ID: 26542806
[TBL] [Abstract][Full Text] [Related]
38. SCF
O'Brien S; Kelso S; Steinhart Z; Orlicky S; Mis M; Kim Y; Lin S; Sicheri F; Angers S
EMBO Rep; 2022 Dec; 23(12):e55044. PubMed ID: 36278408
[TBL] [Abstract][Full Text] [Related]
39. CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.
Zhang E; Chen S; Tang H; Fei C; Yuan Z; Mu X; Qin Y; Liu H; Fan Y; Tan M; Wang X
Cancer Sci; 2022 Jan; 113(1):91-108. PubMed ID: 34741373
[TBL] [Abstract][Full Text] [Related]
40. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
